Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome

Investigative Ophthalmology and Visual Science

Volumn 42, Issue 1, 2001, Pages 101-110

  Tsubota, K ^a   Fujita, H ^a   Tadano, K ^a   Takeuchi, T ^a   Murakami, T ^a   Saito, I ^a   Hayashi, Y ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ACINAR CELL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LACRIMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SJOEGREN LARSSON SYNDROME;

ADMINISTRATION, TOPICAL; ANIMALS; APOPTOSIS; CHEMOTAXIS, LEUKOCYTE; CYCLOSPORINE; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOSUPPRESSIVE AGENTS; LACRIMAL APPARATUS; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; OPHTHALMIC SOLUTIONS; SJOGREN'S SYNDROME; TEARS;

EID: 0035170074     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Zur kenntnis keratoconjunctivitis sicca
2. Lymphocyte phenotype and function of pseudolymphoma associated with Sjögren's syndrome
3. Sjögren's syndrome: Proposed criteria for classification
4. Pathogenesis of Sjögren's syndrome
5. Decreased reflex tearing is associated with lymphocytic infiltration in lacrimal glands
6. Biopsy of labial salivary glands and lacrimal glands in the diagnosis of Sjögren's syndrome
7. +T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome
8. Mikulicz's disease and Sjögren's syndrome
9. Granzyme A and perforin expressed in the lacrimal gland of patients with Sjögren's syndrome
10. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family
11. Spontaneous canine keratoconjunctivitis sicca: A useful model for human keratoconjunctivitis sicca: Treatment with cyclosporine eye drops
12. Tear flow in cyclosporine recipients
13. Longitudinal tear study after cyclosporine in kidney transplant recipients
14. A dose-ranging clinical trial to assess the safety and efficacy of cyclosporine ophthalmic emulsion in patients with keratoconjunctivitis sicca
15. The safety and efficacy of cyclosporine (0.05, 0.1, 0.2 and 0.4%) and vehicle ophthalmic emulsions in the treatment of moderate to severe keratoconjunctivitis sicca (KCS)
16. Use of topical cyclosporin A in a primary Sjögren's syndrome mouse model
17. Experimental autoimmune encephalomyelitis: The antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system
18. Checkpoints in the progression of autoimmune disease: Lessons from diabetes models
19. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome
20. Transfer of human serum lgG to non obese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome
21. Ultrastructural and immunocytochemical aspects of lymphocytic submandibulitis in the nonobese diabetes (NOD) mouse
22. Characterization of antinuclear autoantibodies present in the serum from nonobese diabetic (NOD) mice
23. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjögren's syndrome
24. Anti-120-kDa a-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome
25. Histologic examination of the NOD-mouse lacrimal glands, a potential model for idiopathic autoimmune dacryoadenitis in Sjögren's syndrome
26. Gender- and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoimmune and non-autoimmune mice
27. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome
28. Functional changes in salivary glands of autoimmune disease-prone NOD mice
29. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice
30. A new mutation involving the sublingual gland in NFS/N mice: Partially attested mucous cell differentiation
31. Induction of experimental autoallergic sialadenitis
32. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
33. Morphology and function of lacrimal gland acinar cells in primary culture
34. Substitute modulation of morphology, growth and tear protein production by cultured human lacrimal gland epithetial cells
35. Estrogen deficiency accelerates autoimmune excrinopathy in murine Sjögren's syndrome through Fas-mediated apoptosis
36. Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-sicd mouse in the absence of detectable lymphocytic infiltration: A potential trigger for sialoadenitis of NOD mice
37. Cyclosporin inhibits intercellular adhesion molecule-1 expression and reduces mast cell numbers in the asebia mouse model of chronic skin inflammation
38. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A
39. The role of Fas in autoimmune diabetes